These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15030288)

  • 1. Involvement of cardiomyocyte survival-apoptosis balance in hypertensive cardiac remodeling.
    Fortuño MA; López N; González A; Díez J
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):293-307. PubMed ID: 15030288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apoptosis in remodeling after myocardial infarction.
    Takemura G; Fujiwara H
    Pharmacol Ther; 2004 Oct; 104(1):1-16. PubMed ID: 15500905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in hypertensive heart disease: a clinical approach.
    González A; Ravassa S; López B; Loperena I; Querejeta R; Díez J
    Curr Opin Cardiol; 2006 Jul; 21(4):288-94. PubMed ID: 16755196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An "I" on cardiac hypertrophic remodelling: imidazoline receptors and heart disease.
    Mukaddam-Daher S
    Can J Cardiol; 2012; 28(5):590-8. PubMed ID: 22483786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM; Vela D
    Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling cardiomyocyte survival.
    de Jonge N; Goumans MJ; Lips D; Hassink R; Vlug EJ; van der Meel R; Emmerson CD; Nijman J; de Windt L; Doevendans PA
    Novartis Found Symp; 2006; 274():41-51; discussion 51-7, 152-5, 272-6. PubMed ID: 17019805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between autophagy and apoptosis in heart disease.
    Nishida K; Yamaguchi O; Otsu K
    Circ Res; 2008 Aug; 103(4):343-51. PubMed ID: 18703786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine.
    Duguay D; Pesant S; Deschepper CF; deBlois D
    J Hypertens; 2007 Jun; 25(6):1291-9. PubMed ID: 17563544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte apoptosis in heart failure.
    van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
    Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.
    Abbate A; Scarpa S; Santini D; Palleiro J; Vasaturo F; Miller J; Morales C; Vetrovec GW; Baldi A
    Int J Cardiol; 2006 Aug; 111(3):371-6. PubMed ID: 16257070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac hypertrophy: molecular and cellular events].
    Carreño JE; Apablaza F; Ocaranza MP; Jalil JE
    Rev Esp Cardiol; 2006 May; 59(5):473-86. PubMed ID: 16750145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a new paradigm about hypertensive heart disease.
    Díez J
    Med Clin North Am; 2009 May; 93(3):637-45. PubMed ID: 19427496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease.
    Sato H; Shiraishi I; Takamatsu T; Hamaoka K
    J Mol Cell Cardiol; 2007 Sep; 43(3):254-61. PubMed ID: 17631310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes.
    Heger J; Peters SC; Piper HM; Euler G
    J Cell Physiol; 2009 Aug; 220(2):515-23. PubMed ID: 19415695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiologic role of myocardial hypertrophy, microcirculatory dysfunction and cardiomyocyte apoptosis in aortic stenosis].
    Lotrionte M; Galiuto L; Biondi-Zoccai GG; Abbate A
    G Ital Cardiol (Rome); 2006 Jul; 7(7):437-44. PubMed ID: 16977783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular and cellular mechanisms of myocardial remodeling in heart failure].
    Kremneva LV; Abaturova OV
    Klin Med (Mosk); 2003; 81(2):4-7. PubMed ID: 12685226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte apoptosis in hypertensive cardiomyopathy.
    González A; Fortuño MA; Querejeta R; Ravassa S; López B; López N; Díez J
    Cardiovasc Res; 2003 Sep; 59(3):549-62. PubMed ID: 14499856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
    Sirker A; Zhang M; Murdoch C; Shah AM
    Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.